Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07269990Phase 1Active, not recruiting
Phase 1 trial in Maxillary atrophy (5 arms), sponsored by University of Foggia. Primary endpoints: Percentage of residual biomaterial remaining in situ at 4 months and Percentage of newly formed bone in the regenerated area at 4 months. Started Jul 2023; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07269990.